Cargando…
A Case Report on Varenicline Induced Delirium in an Alcohol and Nicotine Dependent Patient
Varenicline is a smoking cessation agent. Varenicline acts as a partial agonist of α(4)β(2) neuronal nicotinic acetylcholine receptor and prevents nicotine binding to the same. It also causes dopamine (DA) stimulation that decreases craving and symptoms of dependence. A 40-year-old male diagnosed wi...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649805/ https://www.ncbi.nlm.nih.gov/pubmed/26664090 http://dx.doi.org/10.4103/0253-7176.162926 |